STOCK TITAN

Liquidia Rajeev Saggar sells 9,218 common shares

The chief medical officer's sale covered taxes tied to restricted and performance stock unit settlements and followed a plan adopted December 15, 2023.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Liquidia Corp (LQDA) Chief Medical Officer Rajeev Saggar sold 9,218 common shares on October 12, 2026, at $28.48 per share. The sale covered taxes associated with settlements of restricted and performance stock units and was made under a Rule 10b5-1 plan adopted December 15, 2023.

Saggar's October 9, 2026 transactions also included performance stock unit conversions into common stock. As of October 9, 2026, Saggar Legacy Trust held 15,099 shares indirectly; Saggar is the trust's trustee.

Insider Saggar Rajeev
Role Chief Medical Officer
Sold 9,218 shs ($263K)
Approx. gross sale proceeds $263K
Type Security Shares Price Value
Sale Common Stock F5, F6, F1, F3 9,218 $28.48 $263K
Exercise Performance Stock Units F1 3,530 $0.00 $0.00
Exercise Performance Stock Units F1 4,486 $0.00 $0.00
Exercise Common Stock F2, F1, F3 3,530 -- --
Exercise Common Stock F4, F1, F3 4,486 -- --
holding Common Stock F7 -- -- --
Holdings After Transaction: Performance Stock Units — 58,030 contracts (Direct); Common Stock — 126,368 shares (Direct); Common Stock — 15,099 shares (Indirect, See footnote)
Footnotes (7)
  1. F1. Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
  2. F2. On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 38,838 have vested as of the date of this Form 4.
  3. F3. Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
  4. F4. On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,404 have vested as of the date of this Form 4.
  5. F5. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
  6. F6. These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.
  7. F7. The securities are held by Saggar Legacy Trust ("Trust"). The Reporting Person is the trustee of the Trust.
Common shares sold 9,218 shares October 12, 2026
Sale price $28.48 per share October 12, 2026
Indirect common shares held 15,099 shares Saggar Legacy Trust, as of October 9, 2026
Performance stock units granted 56,492 PSUs Granted January 11, 2024
Performance stock units vested 38,838 PSUs Of the PSUs granted January 11, 2024; vested as of the Form 4 date
Performance stock units granted 71,780 PSUs Granted January 11, 2025
Performance stock units vested 31,404 PSUs Of the PSUs granted January 11, 2025; vested as of the Form 4 date
Rule 10b5-1 plan regulatory
"Transaction effected pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Performance stock units ("PSUs") financial
"Performance stock units ("PSUs") convert into common stock"
restricted stock units ("RSUs") financial
"unvested restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
time-based vesting schedule financial
"vest upon the following time-based vesting schedule"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LQDA shares did Chief Medical Officer Rajeev Saggar sell, and at what price?

Liquidia Corp Chief Medical Officer Rajeev Saggar sold 9,218 shares of common stock on October 12, 2026, at $28.48 per share. The sale covered taxes associated with settlements of restricted and performance stock units and was made under a Rule 10b5-1 plan adopted December 15, 2023.

How many of Rajeev Saggar's LQDA performance stock units had vested?

The footnotes state that 38,838 of 56,492 PSUs granted January 11, 2024, and 31,404 of 71,780 PSUs granted January 11, 2025, had vested as of the Form 4 date.

How many LQDA shares did Saggar Legacy Trust hold?

Saggar Legacy Trust held 15,099 shares of Liquidia common stock indirectly as of October 9, 2026. Rajeev Saggar is the trust's trustee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Saggar Rajeev

(Last)(First)(Middle)
419 DAVIS DRIVE
SUITE 100

(Street)
MORRISVILLE NORTH CAROLINA 27560

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Liquidia Corp [ LQDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/09/2026M3,530(2)A(1)131,100(3)D
Common Stock10/09/2026M4,486(4)A(1)135,586(3)D
Common Stock10/12/2026S(5)9,218(6)D$28.48(1)126,368(3)D
Common Stock15,099ISee footnote(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units(1)10/09/2026M3,530 (1) (1)Common Stock3,530$017,654D
Performance Stock Units(1)10/09/2026M4,486 (1) (1)Common Stock4,480$040,376D
Explanation of Responses:
1. Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
2. On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 38,838 have vested as of the date of this Form 4.
3. Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
4. On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,404 have vested as of the date of this Form 4.
5. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
6. These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.
7. The securities are held by Saggar Legacy Trust ("Trust"). The Reporting Person is the trustee of the Trust.
/s/ Dr. Rajeev Saggar10/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading